FDA Peptide Update: Category 2 Removals Explained In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking FDA takes first step in possible reversal of ban on some peptides The Washington Post BPC 157: Miracle Healing Peptide or Hidden Danger? Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives